Discover the reality behind Rheumatoid Arthritis, from its early onset potential to exercise benefits, backed by latest ...

We’ll discuss the distinct traits of psoriatic arthritis in Black patients, and the various environmental and genetic factors ...

Genetically predicted rheumatoid arthritis (RA) is causally associated with prostate cancer (PCa), according to a s ...

Identify triggers, recognize symptoms, and manage RA flare-ups effectively with lifestyle, medication, and support for better ...

Although sustained remission free of disease-modifying antirheumatic drugs “does not seem attainable” for patients with ...

The following is a summary of “Exploring the general practitioners’ perception of the inter-professional care of rheumatoid ...

While knee replacement surgery is life-changing for individuals with final-stage arthritis, it is crucial to explore less ...

This systematic review of real-world observational studies demonstrated the effectiveness of Janus kinase (JAK) inhibitors in ...

The following is a summary of “Efficacy and safety of first-line targeted synthetic DMARDs in rheumatoid arthritis patients with chronic kidney disease,” published in the January 2025 issue of ...

The biosimilar's safety and immunogenicity profiles were found to be comparable to those of the reference product in the ...

Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.

Alvotech and Teva announced FDA acceptance of the Biologics License Application (BLA) for AVT05, a proposed biosimilar ...